1160 related articles for article (PubMed ID: 20426937)
41. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China.
Jin YK; Xie ZD; Yang S; Lu G; Shen KL
Chin Med J (Engl); 2010 Jun; 123(11):1426-30. PubMed ID: 20819601
[TBL] [Abstract][Full Text] [Related]
42. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
[TBL] [Abstract][Full Text] [Related]
43. Comparative study of biomarkers for the early identification of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in infectious mononucleosis.
Cai L; Xing Y; Xia Y; Zhang Z; Luo Z; Tang Y; Chen Y; Xu X
BMC Infect Dis; 2023 Oct; 23(1):728. PubMed ID: 37880605
[TBL] [Abstract][Full Text] [Related]
44. Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus.
Shi J; Chu C; Yu M; Zhang D; Li Y; Fan Y; Yu Y; Luo Y; Zhou W
Ital J Pediatr; 2021 Jan; 47(1):3. PubMed ID: 33413556
[TBL] [Abstract][Full Text] [Related]
45. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
Ali S; AlThubaiti S; Renzi S; Krueger J; Chiang KY; Naqvi A; Schechter T; Punnett A; Ali M
Pediatr Transplant; 2019 Feb; 23(1):e13319. PubMed ID: 30417487
[TBL] [Abstract][Full Text] [Related]
46. [Monitoring of Epstein-Barr virus-infected cells by flow cytometer permits early diagnosis and evaluation of disease progression in EBV-associated hemophagocytic lymphohistiocytosis].
Fukuda M; Nishimura R; Araki R; Kuroda R; Mase S; Nakagawa Y; Tone Y; Maeba H; Wada T; Kasahara Y; Yachie A
Rinsho Ketsueki; 2012 Mar; 53(3):337-41. PubMed ID: 22499051
[TBL] [Abstract][Full Text] [Related]
47. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Chinese children: a primary study on clinical characteristics and gene mutations].
Liu R; Shi X; Li J; Hu T; Cao J; Sun Y; Tong C; Liu H
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(25):1941-6. PubMed ID: 25253006
[TBL] [Abstract][Full Text] [Related]
48. Fatal Epstein-Barr virus infection in a case of familial hemophagocytic lymphohistiocytosis with syntaxin-11 mutation.
Albayrak M; Kaya Z; Yilmaz-Keskin E; Stadt UZ; Koçak U; Gürsel T
Turk J Pediatr; 2009; 51(4):371-4. PubMed ID: 19950846
[TBL] [Abstract][Full Text] [Related]
49. [Clinical analyses of 80 hemophagocytic lymphohistiocytosis patients with Epstein-Barr viremia].
Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Li S; Tang R; Huang W; Chen J; Pei R; Wang Z
Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(36):2841-3. PubMed ID: 25534103
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis.
Ahn JS; Rew SY; Shin MG; Kim HR; Yang DH; Cho D; Kim SH; Bae SY; Lee SR; Kim YK; Kim HJ; Lee JJ
Am J Hematol; 2010 Sep; 85(9):719-22. PubMed ID: 20652965
[TBL] [Abstract][Full Text] [Related]
51. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
[TBL] [Abstract][Full Text] [Related]
52. Early Use of Blood Purification in Severe Epstein-Barr Virus-Associated Hemophagocytic Syndrome.
Huang P; Huang C; Xu H; Lu J; Tian R; Wang Z; Chen Y
Pediatrics; 2020 Jun; 145(6):. PubMed ID: 32430444
[TBL] [Abstract][Full Text] [Related]
53. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
[TBL] [Abstract][Full Text] [Related]
54. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
55. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Yin Q; Wang J; Wang Z
Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294
[TBL] [Abstract][Full Text] [Related]
56. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
[TBL] [Abstract][Full Text] [Related]
57. [Characteristic and prognosis of patients with non-EBV infection-associated hemophagocytic lymphohistiocytosis].
You YH; Wang JS; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2022 Feb; 43(2):128-133. PubMed ID: 35381673
[No Abstract] [Full Text] [Related]
58. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.
Fox CP; Shannon-Lowe C; Gothard P; Kishore B; Neilson J; O'Connor N; Rowe M
Clin Infect Dis; 2010 Jul; 51(1):66-9. PubMed ID: 20504238
[TBL] [Abstract][Full Text] [Related]
60. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors.
Park HS; Kim DY; Lee JH; Lee JH; Kim SD; Park YH; Lee JS; Kim BY; Jeon M; Kang YA; Lee YS; Seol M; Lee YJ; Lim YS; Jang S; Park CJ; Chi HS; Lee KH
Ann Hematol; 2012 Jun; 91(6):897-904. PubMed ID: 22147006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
